Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when SHC files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSotera Health stockholders approve routine annual meeting matters, elect four directors
Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read
Key Changes
-
low
Stockholders elected four Class III directors (Cunningham, Kyle, Petrella, Simon) to three-year terms expiring in 2029, with vote totals ranging from 226M to 260M shares in favor.
Item 5.07 verify on EDGAR → -
low
Advisory vote on executive compensation passed with 257.7M votes in favor, indicating shareholder support for the company's pay practices.
Item 5.07 verify on EDGAR → -
low
Ernst & Young LLP ratified as independent auditor for fiscal 2026 with 267.3M votes in favor, maintaining continuity in external audit relationship.
Item 5.07 verify on EDGAR →
Summary
Sotera Health held its 2026 annual stockholder meeting on May 21, with all three proposals passing by comfortable margins. The company's four Class III director nominees were elected to three-year terms, the executive compensation program received advisory approval, and Ernst & Young was ratified as the external auditor for 2026. These are standard annual meeting items with no surprises or contested votes.
For retail investors, this filing confirms business-as-usual governance with no material changes to board composition or auditor relationships. The strong vote totals on executive compensation suggest shareholders are satisfied with current pay practices. Watch for the company's proxy statement later this year for details on any changes to director compensation or executive incentive structures heading into 2027.
Section-by-Section Diff
Event · Item 5.07 — Submission of Matters to a Vote of Security Holders
Sotera Health held its 2026 annual meeting on May 21, 2026, electing four Class III directors, approving executive compensation, and ratifying Ernst & Young LLP as auditor.
Show 2 minor / wording changes
Added in current filing · verify on EDGAR →
approved, on an advisory basis, the compensation of the Company’s named executive officers
Stockholders approved the compensation of the company's named executive officers on an advisory basis with approximately 257.7 million votes in favor, 6.6 million against, and 51,797 abstentions. This non-binding say-on-pay vote indicates shareholder support for the executive compensation program.
Added in current filing · verify on EDGAR →
ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026
Stockholders ratified Ernst & Young LLP as the independent auditor for fiscal year 2026 with approximately 267.3 million votes in favor, 223,069 against, and 55,857 abstentions. This routine approval confirms continuity in the company's external audit relationship.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · May 24, 2026 · How we verify